Financial firms (RBC, Citigroup, Morgan Stanley) issued rating and price target updates for 10X Genomics.
3 reports, 1 independent
Updated Sep 11
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Financial firms (RBC, Citigroup, Morgan Stanley) issued rating and price target updates for 10X Genomics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
10X Genomics
American biotechnology company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
-
Citigroup
American investment bank and financial services corporation
Related events
- Royal Bank of Canada, Jefferies Financial Group, and Morgan Stanley issued rating updates on August 18, 2026.
- Royal Bank of Canada, Citigroup, and Morgan Stanley issued price target and rating updates on August 27, 2026.
- RBC raised its price objective, Citigroup reaffirmed its outperform rating, and Bank of America reiterated its neutral rating for Addus HomeCare Corporation.
- Royal Bank of Canada reaffirmed rating, Citigroup began coverage, and Morgan Stanley boosted price target on Arrowhead Pharmaceuticals.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.